- AU$7.89m
- AU$3.87m
- AU$0.18m
Brief: Invex Therapeutics Seeks Trading Halt
Brief: Invex Therapeutics Says Got HREC And TGA Approval To Commence Phase 3 In Australia
Australia's Invex Therapeutics climbs on Phase III nod in UK for Presendin drug
Brief: Invex Therapeutics Says Got UK Approval To Commence Phase Iii Trial
Australia Stock Exchange release from INVEX THERAPEUTI : Invex to Present at Upcoming Tech Biotech Broker Briefing
Australia Stock Exchange release from INVEX THERAPEUTI : Half Yearly Report and Accounts
Australia Stock Exchange release from INVEX THERAPEUTI : PRE_NR Ends: 16:06:43
Australia Stock Exchange release from INVEX THERAPEUTI : Upcoming Presentations at 48th Annual NANOS Meeting
Australia Stock Exchange release from INVEX THERAPEUTI : New Executive Director and Chairman Agreements
Australia Stock Exchange release from INVEX THERAPEUTI : PRE_NR Ends: 09:05:26
Australia Stock Exchange release from INVEX THERAPEUTI : Quarterly Activities/Appendix 4C Cash Flow Report
Australia Stock Exchange release from INVEX THERAPEUTI : PRE_NR Ends: 09:47:47
Australia Stock Exchange release from INVEX THERAPEUTI : Notice of Investor Call and Appendix 4C
Australia Stock Exchange release from INVEX THERAPEUTI : Change of Registry Address
Australia Stock Exchange release from INVEX THERAPEUTI : UK R&D Tax Rebate
Australia Stock Exchange release from INVEX THERAPEUTI : Appointment IIH EVOLVE Phase III Trial Steering Group Chair
Australia Stock Exchange release from INVEX THERAPEUTI : PRE_NR Ends: 10:37:50
Australia Stock Exchange release from INVEX THERAPEUTI : Results of Meeting
Australia Stock Exchange release from INVEX THERAPEUTI : Chairman's Address to Shareholders at AGM